Advertisement
Home »

Surgical treatment of pelvic lipomatosis: a systematic review of 231 cases.

Jan 01, 2024

ABOUT THE EXPERTS

  • Mancheng Xia

    Department of Urology, Peking University First Hospital.

    Institution of Urology, Peking University.

    Beijing Key Laboratory of Urogenital Diseases (Male) Molecular Diagnosis and Treatment Center.

    National Urological Cancer Center, Beijing, 100034, China.

    Shengwei Xiong

    Department of Urology, Peking University First Hospital.

    Institution of Urology, Peking University.

    Beijing Key Laboratory of Urogenital Diseases (Male) Molecular Diagnosis and Treatment Center.

    National Urological Cancer Center, Beijing, 100034, China.

    Zhihua Li

    Department of Urology, Peking University First Hospital.

    Institution of Urology, Peking University.

    Beijing Key Laboratory of Urogenital Diseases (Male) Molecular Diagnosis and Treatment Center.

    National Urological Cancer Center, Beijing, 100034, China.

    Shubo Fan

    Department of Urology, Peking University First Hospital.

    Institution of Urology, Peking University.

    Beijing Key Laboratory of Urogenital Diseases (Male) Molecular Diagnosis and Treatment Center.

    National Urological Cancer Center, Beijing, 100034, China.

    Yuke Chen

    Department of Urology, Peking University First Hospital.

    Institution of Urology, Peking University.

    Beijing Key Laboratory of Urogenital Diseases (Male) Molecular Diagnosis and Treatment Center.

    National Urological Cancer Center, Beijing, 100034, China.

    Liqun Zhou

    Department of Urology, Peking University First Hospital.

    Institution of Urology, Peking University.

    Beijing Key Laboratory of Urogenital Diseases (Male) Molecular Diagnosis and Treatment Center.

    National Urological Cancer Center, Beijing, 100034, China.

    Kai Zhang

    Department of Urology, Peking University First Hospital.

    Institution of Urology, Peking University.

    Beijing Key Laboratory of Urogenital Diseases (Male) Molecular Diagnosis and Treatment Center.

    National Urological Cancer Center, Beijing, 100034, China.

    Xuesong Li

    Department of Urology, Peking University First Hospital.

    Institution of Urology, Peking University.

    Beijing Key Laboratory of Urogenital Diseases (Male) Molecular Diagnosis and Treatment Center.

    National Urological Cancer Center, Beijing, 100034, China.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement